Free webinar: Are we measuring the quality of life of prostate cancer patients effectively?
The webinar: “Are we measuring the quality of life of prostate cancer patients effectively” is addressed to the general public.
It will take place on 5 November from 12:30 to 13:30 PM CET.
Currently, 1 in 7 men in Europe will develop detectable prostate cancer before the age of 85. More than two million men in Europe are living with this disease, today. (Reference: Eurostats)
The purpose of this webinar, which will take place during the Movember campaign, is to raise awareness about prostate cancer and the importance of international academic research. The speakers are prostate cancer and quality of life experts and representative from a patient organisation.
The main topic will focus on analysis of the Europa Uomo survey results indicate that any treatment apart from active surveillance may negatively affect quality of life, and that for many men these effects may be greater than previously thought.
EORTC quality of life group have been developing questionnaires for clinical trials over 40 years, with the EORTC QLQ-C30 and the EORTC QLQ-PR25 being used to evaluate the quality of life issues among prostate cancer patients. These validated questionnaires and its availability in various languages provide information on the benefit-risk assessment of prostate cancer treatments from the perspective of the patients.
For more information, visit the webinar’s webpage.